Endava Launches Global Advisory Board Amid AI-Driven Transformation
The Global Advisory Board brings together renowned business leaders to advise, guide and champion Endava’s leadership position within the technology industry LONDON–(BUSINESS... Read more.
OS Therapies Receives Positive FDA Meeting Feedback on Regulatory Pathway for Accelerated Approval of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
Company has requested End of Phase 2 Meeting and Breakthrough Therapy Designation (BTD) based upon the positive FDA Meeting feedback NEW YORK–(BUSINESS WIRE)–OS... Read more.
FourKites Unveils Premier AI Conference for the Supply Chain Community
Celebrating a decade of innovation, FourKites Summit 2025 focuses on AI agents and autonomous supply chain execution CHICAGO–(BUSINESS WIRE)–FourKites®,... Read more.
Neuron23 Announces $96.5 Million Series D Financing and First Patient Dosed in Global Phase 2 NEULARK Clinical Trial of NEU-411 for Early Parkinson’s Disease
NEULARK trial to evaluate NEU-411, a brain-penetrant, potent and selective LRRK2 inhibitor, in people with LRRK2-driven Parkinson’s disease; topline data anticipated... Read more.
Soluna Expands Long-Term Partnership with Compass Mining
Expands into Project Dorothy 2, Totaling 13 MW ALBANY, N.Y.–(BUSINESS WIRE)–$SLNH #SLNH–Soluna Holdings, Inc. (“Soluna” or the “Company”),... Read more.
XCharge North America and Gateway Fleets Bring Advanced EV Charging to Southern California’s Last-Mile Logistics
RIVERSIDE, Calif.–(BUSINESS WIRE)–XCharge North America (“XCharge NA”), the North American subsidiary of XCHG Limited (NASDAQ: XCH) and a provider... Read more.
Real’s May Agent Survey: Market Momentum Slows as Buyer Leverage Grows
Agents remain optimistic, prioritizing economics and culture over brand in brokerage decisions MIAMI–(BUSINESS WIRE)–The Real Brokerage Inc. (NASDAQ:... Read more.
Results From the World’s First Observational Study of ExoStat Medical’s MicroTREND System Support POMCO2 as an Important Early Indicator of Septic Shock in Critically Ill Patients
PRIOR LAKE, Minn.–(BUSINESS WIRE)–ExoStat Medical, Inc. a medical device company engaged in the research and development of the novel MicroTREND System... Read more.
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine,... Read more.
ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology
Follow-Up to June 5, 2025, Announcement Demonstrates Validated Vaccine Candidate with Strong Translational Potential AUSTIN, Texas–(BUSINESS WIRE)–$IPA... Read more.